Puerarin attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice

NeuroToxicology

Volumn 51, Issue , 2015, Pages 166-171

  Zhao, Shan Shan ^a   Yang, Wei Na ^a   Jin, Hui ^a   Ma, Kai Ge ^a   Feng, Gai Feng ^a,b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Learning and memory; Oxidative stress; Puerarin; Streptozotocin

Indexed keywords

DONEPEZIL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PUERARIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; ISOFLAVONE DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; LEARNING DISORDER; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPORADIC ALZHEIMER DISEASE; TREATMENT DURATION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; LEARNING; MAZE TEST; MEMORY; METABOLISM; PSYCHOLOGY;

ALZHEIMER DISEASE; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; ISOFLAVONES; LEARNING; MALONDIALDEHYDE; MAZE LEARNING; MEMORY; MICE; OXIDATIVE STRESS; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

EID: 84946417075     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2015.10.010     Document Type: Article

References (46)

1. Agrawa R., Tyagi E., Shukla R., Nath C. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology 2009, 56(4):779-787.
2. Chen Z., Zhong C. Oxidative stress in Alzheimer's disease. Neurosci. Bull. 2014, 30(2):271-281.
3. Dringen R., Gutterer J.M., Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 2000, 267(16):4912-4916.
4. Droge W., Kinscherf R. Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid. Redox Signal. 2008, 10(4):661-668.
5. Dumont M., Wille E., Stack C., Calingasan N.Y., Beal M.F., Lin M.T. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J. 2009, 23(8):2459-2466.
6. Grunblatt E., Salkovic-Petrisic M., Osmanovic J., Riederer P., Hoyer S. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J. Neurochem. 2007, 101(3):757-770.
7. Hamilton A., Holscher C. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease. Brain Res. 2012, 1449:83-93.
8. Hoyer S., Lannert H. Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann. N.Y. Acad. Sci. 1999, 893:301-303.
9. Hunter S., Arendt T., Brayne C. The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. Mol. Neurobiol. 2013, 48(3):556-570.
10. Iqbal K., Grundke-Iqbal I. Alzheimer's disease, a multifactorial disorder seeking multitherapies. Alzheimers Dement. 2010, 6(5):420-424.
11. Ishrat T., Parveen K., Khan M.M., Khuwaja G., Khan M.B., Yousuf S., et al. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res. 2009, 1281:117-127.
12. Javed H., Khan M.M., Khan A., Vaibhav K., Ahmad A., Khuwaja G., et al. S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res. 2011, 1389:133-142.
13. Jin H., Wang W., Zhao S., Yang W., Qian Y., Jia N., Feng G. Aβ-HBc virus-like particles immunization without additional adjuvant ameliorates the learning and memory and reduces Aβ deposit in PDAPP mice. Vaccine 2014, 32(35):4450-4456.
14. Khan M.B., Khan M.M., Khan A., Ahmed M.E., Ishrat T., Tabassum R., et al. Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model. Neurochem. Int. 2012, 61(7):1081-1093.
15. Kraska A., Santin M.D., Dorieux O., Joseph-Mathurin N., Bourrin E., Petit F., et al. In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin. PLoS ONE 2012, 7(9):e46196.
16. Lester-Coll N., Rivera E.J., Soscia S.J., Doiron K., Wands J.R., de la Monte S.M. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J. Alzheimers Dis. 2006, 9(1):13-33.
17. Li R., Zheng N., Liang T., He Q., Xu L. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats. Brain Res. 2013, 1517:28-35.
18. Lin F., Xie B., Cai F., Wu G. Protective effect of puerarin on β-amyloid-induced neurotoxicity in rat hippocampal neurons. Arzneimittelforschung 2012, 62(4):187-193.
19. Moreira P.I., Smith M.A., Zhu X., Honda K., Lee H.G., Aliev G., et al. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?. Drug News Perspect. 2005, 18(1):13-19.
20. Ozkay U.D., Can O.D., Ozkay Y., Oztürk Y. Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits. Pharmacol. Rep. 2012, 64(4):834-847.
21. Padurariu M., Ciobica A., Lefter R., Serban I.L., Stefanescu C., Chirita R. The oxidative stress hypothesis in Alzheimer's disease. Psychiatr. Danub. 2013, 25(4):401-409.
22. Prasain J.K., Jones K., Brissie N., Moore R., Wyss J.M., Barnes S. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J. Agric. Food Chem. 2004, 52(12):708-712.
23. Rocchi A., Pellegrini S., Siciliano G., Murri L. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res. Bull. 2003, 61(1):1-24.
24. Salkovic-Petrisic M., Knezovic A., Hoyer S., Riederer P. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. J. Neural Transm. 2013, 120(1):233-252.
25. Saxena G., Singh S.P., Agrawal R., Nath C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur. J. Pharmacol. 2008, 581(3):283-289.
26. Song J., Hur B.E., Bokara K.K., Yang W., Cho H.J., Park K.A., et al. Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model. Yonsei Med. J. 2014, 55(3):689-699.
27. Sonkusare S., Srinivasan K., Kaul C., Ramarao P. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci. 2005, 77(1):1-14.
28. Su B., Wang X., Nunomura A., Moreira P.I., Lee H.G., Perry G., et al. Oxidative stress signaling in Alzheimer's disease. Curr. Alzheimer Res. 2008, 5(6):525-532.
29. Sultana R., Butterfield D.A. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies. J. Alzheimers Dis. 2013, 33:S243-S251.
30. Texel S.J., Mattson M.P. Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease. Antioxid. Redox Signal. 2011, 14(8):1519-1534.
31. Thies W., Bleiler L. 2013 Alzheimer's disease facts and figures. Alzheimers Dement. 2013, 9(2):208-245. Alzheimer's Association.
32. Vina J., Lloret A., Giraldo E., Badia M.C., Alonso M.D. Antioxidant pathways in Alzheimer's disease: possibilities of intervention. Curr. Pharm. Des. 2011, 17(35):3861-3864.
33. Waring S.C., Rosenberg R.N. Genome-wide association studies in Alzheimer disease. Arch. Neurol. 2008, 65(3):329-334.
34. Wang X., Wang W., Li L., Perry G., Lee H.G., Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim. Biophys. Acta 2014, 1842(8):1240-1247.
35. Wei S.Y., Chen Y., Xu X.Y. Progress on the pharmacological research of puerarin: a review. Chin. J. Nat. Med. 2014, 12(6):407-414.
36. Weinstock M., Shoham S. Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J. Neural.Transm. 2004, 111(3):347-366.
37. Wong K.H., Li G.Q., Li K.M., Razmovski-Naumovski V., Chan K. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J. Ethnopharmacol. 2011, 134(3):584-607.
38. Wu H.Q., Guo H.N., Wang H.Q., Chang M.Z., Zhang G.L., Zhao Y.X. Protective effects and mechanism of puerarin on learning-memory disorder after global cerebral ischemia-reperfusion injury in rats. Chin. J. Integr. Med. 2009, 15(1):54-59.
39. Wu K., Liang T., Duan X., Xu L., Zhang K., Li R. Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. Food Chem. Toxicol. 2013, 60:341-347.
40. Wu L., Qiao H., Li Y., Li L. Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats. Phytomedicine 2007, 14(10):652-658.
41. Xu X., Hu Y., Ruan Q. Effects of puerarin on learning-memory and amino acid transmitters of brain in ovariectomized mice. Planta Med. 2004, 70(7):627-631.
42. Xu X., Zhang Z. Effects of puerarin on synaptic structural modification in hippocampus of ovariectomized mice. Planta Med. 2007, 73(10):1047-1053.
43. Yang W.N., Han H., Hu X.D., Feng G.F., Qian Y.H. The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress. Pharmacol. Biochem. Behav. 2013, 114:31-36.
44. Zhang H.Y., Liu Y.H., Wang H.Q., Xu J.H., Hu H.T. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol. Int. 2008, 32(10):1230-1237.
45. Zhou Y., Xie N., Li L., Zou Y., Zhang X., Dong M. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. Int. J. Neuropsychopharmacol. 2014, 17(4):635-644.
46. Zou Y., Hong B., Fan L., Zhou L., Liu Y., Wu Q., et al. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway. Free Radical Res. 2013, 47(1):55-63.